Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 36,409 | 32,291 | 43,251 | 58,176 | 144,244 |
| Marketable Securities | 241,030 | 293,105 | 397,793 | 508,675 | 490,399 |
| Receivables | 25,170 | 24,466 | 22,731 | 21,179 | 14,570 |
| Inventories | 6,356 | 5,976 | 4,532 | 9,410 | 20,773 |
| TOTAL | $324,740 | $368,977 | $481,076 | $616,775 | $686,230 |
| Non-Current Assets | |||||
| PPE Net | 6,162 | 6,580 | 6,943 | 7,479 | 7,996 |
| Intangibles | 104,205 | 105,174 | 101,182 | 104,443 | 106,903 |
| Other Non-Current Assets | 69,303 | 70,390 | 74,346 | 60,216 | 31,721 |
| TOTAL | $179,670 | $182,144 | $182,471 | $172,138 | $146,620 |
| Total Assets | $504,410 | $551,121 | $663,547 | $788,913 | $832,850 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 23,195 | 25,843 | 16,725 | 41,675 | 24,736 |
| Accrued Expenses | 83,916 | 79,641 | 139,580 | 118,991 | 95,712 |
| Other current liabilities | 5,232 | 5,243 | 5,428 | 5,237 | 5,244 |
| TOTAL | $190,038 | $121,268 | $173,229 | $177,908 | $139,433 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,799 | 5,378 | 6,460 | 7,096 | 8,959 |
| Other Non-Current Liabilities | 344,826 | 414,706 | 415,359 | 410,195 | 409,077 |
| TOTAL | $344,826 | $414,706 | $416,247 | $410,195 | $413,651 |
| Total Liabilities | $534,864 | $535,974 | $589,476 | $588,103 | $553,084 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 78,050 | 76,491 | 76,129 | 76,098 | 75,146 |
| Common Shares | 8 | 8 | 8 | 7 | 7 |
| Retained earnings | -1,386,903 | -1,332,092 | -1,261,683 | -1,125,622 | -1,035,449 |
| Other shareholders' equity | -1,016 | -1,634 | -1,892 | -1,456 | -3,653 |
| TOTAL | $-30,454 | $15,147 | $74,071 | $200,810 | $279,766 |
| Total Liabilities And Equity | $504,410 | $551,121 | $663,547 | $788,913 | $832,850 |